JP2017189179A5 - - Google Patents

Download PDF

Info

Publication number
JP2017189179A5
JP2017189179A5 JP2017146473A JP2017146473A JP2017189179A5 JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5 JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017146473 A JP2017146473 A JP 2017146473A JP 2017189179 A5 JP2017189179 A5 JP 2017189179A5
Authority
JP
Japan
Prior art keywords
cell
host cell
virus
bacterial
bacterial dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017146473A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017189179A (ja
JP6666311B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017189179A publication Critical patent/JP2017189179A/ja
Publication of JP2017189179A5 publication Critical patent/JP2017189179A5/ja
Application granted granted Critical
Publication of JP6666311B2 publication Critical patent/JP6666311B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017146473A 2009-07-31 2017-07-28 逆遺伝学系 Active JP6666311B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27315109P 2009-07-31 2009-07-31
US61/273,151 2009-07-31

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012522275A Division JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系

Publications (3)

Publication Number Publication Date
JP2017189179A JP2017189179A (ja) 2017-10-19
JP2017189179A5 true JP2017189179A5 (https=) 2018-02-01
JP6666311B2 JP6666311B2 (ja) 2020-03-13

Family

ID=43018886

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系
JP2017146473A Active JP6666311B2 (ja) 2009-07-31 2017-07-28 逆遺伝学系

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2012522275A Withdrawn JP2013500712A (ja) 2009-07-31 2010-07-30 逆遺伝学系
JP2015215655A Pending JP2016019547A (ja) 2009-07-31 2015-11-02 逆遺伝学系

Country Status (8)

Country Link
US (2) US9821052B2 (https=)
EP (1) EP2459722B1 (https=)
JP (3) JP2013500712A (https=)
KR (1) KR20120039047A (https=)
CN (2) CN104862335A (https=)
AU (1) AU2010277310B2 (https=)
CA (1) CA2769673A1 (https=)
WO (1) WO2011012999A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101323582B1 (ko) 2011-03-17 2013-10-30 충북대학교 산학협력단 Vero 세포 유래의 polⅠ 프로모터 및 이를 포함하는 재조합 벡터
WO2013101783A2 (en) 2011-12-30 2013-07-04 Bio-Rad Laboratories, Inc. Methods and compositions for performing nucleic acid amplification reactions
EP2820126B1 (en) 2012-03-02 2017-05-17 Seqirus UK Limited Influenza virus reassortment
KR20150110494A (ko) 2012-12-03 2015-10-02 노파르티스 아게 재배열 인플루엔자 a 바이러스
US20140274806A1 (en) 2013-03-15 2014-09-18 Synthetic Genomics Vaccines Influenza virus reassortment
MX2015009330A (es) * 2013-01-23 2016-04-15 Novartis Ag Reordenamiento del virus de influenza.
HK1218511A1 (zh) 2013-03-13 2017-02-24 Novartis Ag 乙型流感病毒重配
WO2014145261A2 (en) * 2013-03-15 2014-09-18 University Of Maryland Methods and compositions for in vivo immune stimulation and antigen production
DE202013005130U1 (de) 2013-06-05 2013-09-10 Novartis Ag Influenza Virus Reassortierung
DE202013005100U1 (de) 2013-06-05 2013-08-26 Novartis Ag Influenza Virus Reassortierung
CA2914604A1 (en) 2013-06-06 2014-12-11 Novartis Ag Influenza virus reassortment
JP2018510642A (ja) * 2015-03-27 2018-04-19 カディラ ヘルスケア リミティド 組換え流行性耳下腺炎ウイルスJeryl Lynn2系ワクチン
US10726110B2 (en) * 2017-03-01 2020-07-28 Seven Bridges Genomics, Inc. Watermarking for data security in bioinformatic sequence analysis
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
CN114040979B (zh) * 2019-06-21 2024-06-28 国立大学法人大阪大学 稳定地保持外源基因的人工重组rna病毒的制作方法
CN110305854B (zh) * 2019-07-18 2023-09-15 山东中医药大学 一种携带荧光素酶的重组h3n2亚型流感病毒、构建方法及应用
JP2023502650A (ja) 2019-11-18 2023-01-25 セキラス ピーティーワイ リミテッド 遺伝子再集合インフルエンザウイルスを産生するための方法
CN114395568A (zh) * 2021-10-29 2022-04-26 扬州大学 一种猪流行性腹泻病毒感染性cDNA克隆及其构建方法与应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
WO1995011700A1 (en) 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de) 1996-04-01 1997-10-02 Behringwerke Ag Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
TW570803B (en) 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
WO1999050419A2 (en) 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
ATE384126T1 (de) 1998-06-12 2008-02-15 Sinai School Medicine Interferon induzierende genetisch veränderte attenuierte viren
KR100637937B1 (ko) 1998-06-12 2006-10-23 마운트 시나이 스쿨 오브 메디신 오브 뉴욕 유니버시티 변형된 인터페론 길항물질을 보유하고, 백신 및 약제로사용되는 약독화된 네거티브 가닥 바이러스
GB9916794D0 (en) * 1999-07-16 1999-09-22 Isis Innovation In vitro virus reconstitution
TR200200776T2 (tr) 1999-09-24 2002-06-21 Smithkline Beecham Biologicals S.A. Burun içi grip virüsü aşısı.
JP4698112B2 (ja) 2000-03-03 2011-06-08 一般財団法人化学及血清療法研究所 無血清培養かつ浮遊培養可能な細胞及び当該細胞を用いたワクチン用ウイルスの製造法
MXPA02010642A (es) 2000-04-28 2004-05-17 St Jude Children S Res Hospital Sistema de transfeccion de adn para la generacion de virus de influenza infeccioso.
AU2001264802A1 (en) 2000-05-21 2001-12-03 University Of North Carolina At Chapel Hill Assembly of large viral genomes and chromosomes from subclones
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
JP2004536785A (ja) 2001-02-23 2004-12-09 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規なワクチン
ATE503493T1 (de) 2001-02-23 2011-04-15 Glaxosmithkline Biolog Sa Influenza vakzinzusammensetzungen zur intradermaler verabreichung
TWI228420B (en) 2001-05-30 2005-03-01 Smithkline Beecham Pharma Gmbh Novel vaccine composition
EP1534845A1 (en) * 2002-09-04 2005-06-01 Polymun Scientific Immunbiologische Forschung GmbH Generation of recombinant influenza virus using baculovirus delivery vector
AU2005230708B2 (en) 2004-04-05 2009-01-15 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
NZ551640A (en) 2004-05-20 2010-05-28 Id Biomedical Corp Process for the production of an influenza vaccine
CN101103103A (zh) * 2004-11-19 2008-01-09 威斯康星旧生研究基金会 具有串联转录单位的重组流感病毒载体
ATE547511T1 (de) 2004-12-23 2012-03-15 Medimmune Llc Nichttumorbildende mdck-zellinie zur vermehrung von viren
EP2295542B1 (en) 2004-12-24 2013-01-30 Abbott Biologicals B.V. Rescue of influenza virus
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
RU2008101367A (ru) 2005-06-21 2009-08-10 Медиммун, Ллк (Us) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
US8703095B2 (en) 2005-07-07 2014-04-22 Sanofi Pasteur S.A. Immuno-adjuvant emulsion
CA2627971A1 (en) 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Gmbh & Co Kg. Cell-derived viral vaccines with low levels of residual cell dna by beta-propiolactone treatment
FR2896162B1 (fr) 2006-01-13 2008-02-15 Sanofi Pasteur Sa Emulsion huile dans eau thermoreversible
PT2016194E (pt) 2006-04-19 2015-07-20 Medimmune Llc Métodos e composições para expressar arn viral de polaridade negativa em células caninas
KR101151202B1 (ko) 2006-10-12 2012-06-11 글락소스미스클라인 바이오로지칼즈 에스.에이. 수중유 에멀젼 애주번트를 포함하는 백신
SG177141A1 (en) 2006-12-06 2012-01-30 Novartis Ag Vaccines including antigen from four strains of influenza virus
EP2045323A1 (en) * 2007-10-05 2009-04-08 Avir Green Hills Biotechnology Research Development Trade Ag Linear expression constructs for production of influenza virus particles
CN101932725A (zh) 2007-10-08 2010-12-29 合成基因组股份有限公司 大核酸的装配
CN101302499A (zh) * 2008-06-30 2008-11-12 中国科学院广州生物医药与健康研究院 一种流感病毒疫苗种子株的制备方法
EP2233568A1 (en) * 2009-03-19 2010-09-29 Avir Green Hills Biotechnology Research Development Trade AG Novel method for generation of RNA virus

Similar Documents

Publication Publication Date Title
JP2017189179A5 (https=)
Kobayashi et al. An improved reverse genetics system for mammalian orthoreoviruses
JP2015119730A5 (https=)
Zhou et al. Characterization of uncultivable bat influenza virus using a replicative synthetic virus
Sun et al. Rapid construction of complex plant RNA virus infectious cDNA clones for agroinfection using a yeast-E. coli-Agrobacterium shuttle vector
JP2019011344A5 (https=)
JP2016509864A5 (https=)
EA201791343A1 (ru) Композиции и способы для конструирования вирусного генома in vitro
Zhang et al. Wheat yellow mosaic virus NIb interacting with host light induced protein (LIP) facilitates its infection through perturbing the abscisic acid pathway in wheat
JP2016521553A5 (https=)
JP2010042030A5 (https=)
RU2008101367A (ru) Способы и композиции для экспрессии отрицательной смысловой вирусной рнк в собачьих клетках
RU2008145226A (ru) Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
Griffin et al. Fitness determinants of influenza A viruses
CA2968430C (en) Plasmids and method for obtaining viral particles
JP2016501020A5 (https=)
Mostafa et al. Efficient generation of recombinant influenza a viruses employing a new approach to overcome the genetic instability of HA segments
WO2013030176A3 (en) Live attenuated influenza virus
Shao et al. An efficient and rapid influenza gene cloning strategy for reverse genetics system
Feng et al. Comparing the functions of equine and canine influenza H3N8 virus PA-X proteins: suppression of reporter gene expression and modulation of global host gene expression
Lee Reverse genetics of influenza virus
Park et al. Effects of HA and NA glycosylation pattern changes on the transmission of avian influenza A (H7N9) virus in guinea pigs
CN104195154A (zh) 新城疫病毒Mukteswar中等毒力疫苗株反向遗传操作系统及其应用
Froggatt et al. Influenza A virus segments five and six can harbor artificial introns allowing expanded coding capacity
Kim et al. Glycosylation generates an efficacious and immunogenic vaccine against H7N9 influenza virus